Benjamin Piske

Global Head of Biostatistics

Benjamin discovered his interest in statistics during his mathematics and economics studies at the University of Göttingen, where he attended courses in statistics at the department of medical statistics. Focusing on non-parametric statistics, he completed his MSc in 2003 and started working for a global full-service CRO afterwards.

Benjamin started as a biostatistician in the phase IIIb/IV environment and worked on interventional and non-interventional late phase trials, commercialization work, publication/presentation support, registries, and investigator-driven trials in several therapeutic areas — mainly oncology, haematology and neurology — using a broad range of statistical methods. In the later stages of his career, he expanded his focus to include earlier phases as well.

Beginning in 2008, Benjamin assumed line management responsibilities, overseeing a growing number of staff and placing additional focus on people development and initiatives. Joining Cytel as Senior Director of Biostatistics in 2020, Benjamin led the team of statisticians in North America and was promoted to Global Head of Biostatistics in 2024.